236 related articles for article (PubMed ID: 27586674)
1. The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma.
Kim HJ; Kim MJ; Kim A; Jung CW; Park S; Koh JS; Myung JK
Cancer Res Treat; 2017 Apr; 49(2):509-517. PubMed ID: 27586674
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
3. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
[TBL] [Abstract][Full Text] [Related]
4. Blocking CDK7-Mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
Doolittle WKL; Zhao L; Cheng SY
Thyroid; 2022 Aug; 32(8):937-948. PubMed ID: 35822558
[No Abstract] [Full Text] [Related]
5. Suberoyl bis-hydroxamic acid activates Notch1 signaling and induces apoptosis in anaplastic thyroid carcinoma through p53.
Li J; Zheng X; Gao M; Zhao J; Li Y; Meng X; Qian B; Li J
Oncol Rep; 2017 Jan; 37(1):458-464. PubMed ID: 28004113
[TBL] [Abstract][Full Text] [Related]
6. Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.
Patel PN; Yu XM; Jaskula-Sztul R; Chen H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S497-504. PubMed ID: 24419754
[TBL] [Abstract][Full Text] [Related]
7. FOXD3 regulates anaplastic thyroid cancer progression.
Yin H; Meng T; Zhou L; Zhao F; Li X; Li Y; Hu M; Chen H; Song D
Oncotarget; 2017 May; 8(20):33644-33651. PubMed ID: 28430585
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.
Zhong Z; Hu Z; Jiang Y; Sun R; Chen X; Chu H; Zeng M; Sun C
Oncotarget; 2016 Sep; 7(37):59652-59663. PubMed ID: 27487122
[TBL] [Abstract][Full Text] [Related]
9. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H
Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
[TBL] [Abstract][Full Text] [Related]
11. Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways.
Orlandella FM; Mariniello RM; Iervolino PLC; Auletta L; De Stefano AE; Ugolini C; Greco A; Mirabelli P; Pane K; Franzese M; Denaro M; Basolo F; Salvatore G
Mol Carcinog; 2019 Jul; 58(7):1181-1193. PubMed ID: 30834573
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H
Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881
[TBL] [Abstract][Full Text] [Related]
13. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
14. Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer.
Antognelli C; Moretti S; Frosini R; Puxeddu E; Sidoni A; Talesa VN
Cells; 2019 Jun; 8(6):. PubMed ID: 31174324
[TBL] [Abstract][Full Text] [Related]
15. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
Chen J; Zhao D; Meng Q
Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
[TBL] [Abstract][Full Text] [Related]
17. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
[TBL] [Abstract][Full Text] [Related]
18. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Pan Z; Fang Q; Li L; Zhang Y; Xu T; Liu Y; Zheng X; Tan Z; Huang P; Ge M
Cancer Lett; 2021 Mar; 501():31-42. PubMed ID: 33359451
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
Chin LH; Hsu SP; Zhong WB; Liang YC
Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758
[TBL] [Abstract][Full Text] [Related]
20. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
